Showing 521 - 540 results of 19,550 for search '(( significant increase decrease ) OR ( significant ((teer decrease) OR (a decrease)) ))', query time: 0.47s Refine Results
  1. 521

    Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…UCB-Treg and ruxolitinib combination also downregulates the soluble form of inflammatory cytokines including IFN-γ, IP-10, TNF-α, IL-6, sCD40L, IL-17A, IL-17F, IL-1α, and LIF in cocultures. The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”
  2. 522
  3. 523

    S1 Data - by Miki Doi (15347878)

    Published 2024
    Subjects:
  4. 524

    S1 Fig - by Miki Doi (15347878)

    Published 2024
    Subjects:
  5. 525
  6. 526
  7. 527
  8. 528
  9. 529
  10. 530
  11. 531
  12. 532
  13. 533
  14. 534
  15. 535
  16. 536
  17. 537
  18. 538
  19. 539
  20. 540